News

Comprehensive analysis outlines the potential toxicities of antibody drug conjugates

0
Corporate businessmen working on tablet at office

Over the past two decades, numerous complex cancer therapies called antibody drug conjugates (ADCs) have been tested in clinical trials and approved for use in patients.

‘Butterfly bot’ swims 4X faster than past robots

Previous article

Researchers to develop brain imaging radiotracers for better understanding of Alzheimer’s, autism

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News